← FDA Drug Approvals (Drugs@FDA)

APIXABAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BRECKENRIDGE · Approved 2021-07-26

Drug application

FDA Application #

ANDA209845

Application type

Abbreviated New Drug Application (Generic)

Brand name

APIXABAN

Generic name

Apixaban

Active ingredients

APIXABAN

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

BRECKENRIDGE

First approval

2021-07-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown